Skip to main content
Log in

Co-morbidities in heart failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Heart failure is a clinical syndrome characterized by poor quality of life and high morbidity and mortality. Co-morbidities frequently accompany heart failure and further decrease in both quality of life and clinical outcome. We describe that the prevalence of co-morbidities in patients with heart failure is much higher compared to age-matched controls. We will specifically address the most studied organ-related co-morbidities, that is, renal dysfunction, cerebral dysfunction, anaemia, liver dysfunction, chronic obstructive pulmonary disease, diabetes mellitus and sleep apnoea. The pathophysiologic processes underlying the interaction between heart failure and co-morbid conditions are complex and remain largely unresolved. Although common risk factors are likely to contribute, it is reasonable to believe that factors associated with heart failure might cause other co-morbid conditions. Inflammation, neurohumoral pathway activation and hemodynamic changes are potential factors. We try to provide explanations for the observed association between co-morbidities and heart failure, as well as its impact on survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Authors/Task Force Members, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Document Reviewers, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 14:803–869

    Article  CAS  PubMed  Google Scholar 

  2. Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, Wu AW (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42:1226–1233

    Article  PubMed  Google Scholar 

  3. Zelis R, Sinoway LI, Musch TI, Davis D, Just H (1988) Regional blood flow in congestive heart failure: concept of compensatory mechanisms with short and long time constants. Am J Cardiol 62:2E–8E

    Article  CAS  PubMed  Google Scholar 

  4. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53:582–588

    Article  PubMed  Google Scholar 

  5. Kleijn L, Belonje AM, Voors AA, De Boer RA, Jaarsma T, Ghosh S, Kim J, Hillege HL, Van Gilst WH, Van Veldhuisen DJ, Van der Meer P (2012) Inflammation and anaemia in a broad spectrum of patients with heart failure. Heart 98:1237–1241

    Article  CAS  PubMed  Google Scholar 

  6. van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, Voors AA (2010) Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Card Fail 16:84–90

    Article  PubMed  Google Scholar 

  7. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, Van der Meer P (2008) Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 52:818–827

    Article  PubMed  Google Scholar 

  8. van der Meer P, van Veldhuisen DJ (2009) Anaemia and renal dysfunction in chronic heart failure. Heart 95:1808–1812

    Article  PubMed  Google Scholar 

  9. Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D (2006) Anemia, chronic renal disease and congestive heart failure–the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 38:295–310

    Article  PubMed  Google Scholar 

  10. Westenbrink BD, Visser FW, Voors AA, Smilde TD, Lipsic E, Navis G, Hillege HL, van Gilst WH, van Veldhuisen DJ (2007) Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J 28:166–171

    Article  CAS  PubMed  Google Scholar 

  11. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436–2448

    Article  CAS  PubMed  Google Scholar 

  12. Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL (2004) Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J 147:924–930

    Article  PubMed  Google Scholar 

  13. Klip IT, Comin Colet J, Voors AA, van der Meer P (Submitted) Iron deficiency in chronic heart failure: an international pooled analysis

  14. van der Meer P, Lok DJ, Januzzi JL, de la Porte PW, Lipsic E, van Wijngaarden J, Voors AA, van Gilst WH, van Veldhuisen DJ (2008) Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. Eur Heart J 29:1510–1515

    Article  PubMed  Google Scholar 

  15. Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P, Vellenga E, van Veldhuisen DJ, van Gilst WH (2010) Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail 12(7):676–684

    Article  CAS  PubMed  Google Scholar 

  16. van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH (2005) Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 112:1743–1747

    Article  PubMed  Google Scholar 

  17. Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, Herzog CA (2005) Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 45:391–399

    Article  CAS  PubMed  Google Scholar 

  18. Komajda M, Anker SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, Remme W, Moullet C, Swedberg K, Cleland JG, Poole-Wilson PA (2006) The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J 27:1440–1446

    Article  PubMed  Google Scholar 

  19. Herzog CA, Muster HA, Li S, Collins AJ (2004) Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the medicare population. J Card Fail 10:467–472

    Article  PubMed  Google Scholar 

  20. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, Mancini DM (2003) Hemodilution is common in patients with advanced heart failure. Circulation 107:226–229

    Article  PubMed  Google Scholar 

  21. Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2007) Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 9:440–449

    Article  PubMed  Google Scholar 

  22. Pressler SJ (2008) Cognitive functioning and chronic heart failure: a review of the literature (2002-July 2007). J Cardiovasc Nurs 23:239–249

    Article  PubMed  Google Scholar 

  23. van den Hurk K, Reijmer YD, van den Berg E, Alssema M, Nijpels G, Kostense PJ, Stehouwer CD, Paulus WJ, Kamp O, Dekker JM, Biessels GJ (2011) Heart failure and cognitive function in the general population: the Hoorn Study. Eur J Heart Fail 13:1362–1369

    Article  PubMed  Google Scholar 

  24. Bauer LC, Johnson JK, Pozehl BJ (2011) Cognition in heart failure: an overview of the concepts and their measures. J Am Acad Nurse Pract 23:577–585

    Article  PubMed Central  PubMed  Google Scholar 

  25. Kindermann I, Fischer D, Karbach J, Link A, Walenta K, Barth C, Ukena C, Mahfoud F, Kollner V, Kindermann M, Bohm M (2012) Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study. Eur J Heart Fail 14:404–413

    Article  CAS  PubMed  Google Scholar 

  26. Luijckx GJ, van den Berg MP (2011) Heart failure and the brain, a wake-up call. Eur J Heart Fail 13:597–598

    Article  PubMed  Google Scholar 

  27. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV (2003) Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290:2581–2587

    Article  CAS  PubMed  Google Scholar 

  28. Zuccala G, Pedone C, Cesari M, Onder G, Pahor M, Marzetti E, Lo Monaco MR, Cocchi A, Carbonin P, Bernabei R (2003) The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 115:97–103

    Article  PubMed  Google Scholar 

  29. Dickson VV, Tkacs N, Riegel B (2007) Cognitive influences on self-care decision making in persons with heart failure. Am Heart J 154:424–431

    Article  PubMed  Google Scholar 

  30. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM (2000) Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 71:1033–1047

    CAS  PubMed  Google Scholar 

  31. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130–139

    Article  PubMed  Google Scholar 

  32. Hawkins NM, Jhund PS, Simpson CR, Petrie MC, Macdonald MR, Dunn FG, Macintyre K, McMurray JJ (2010) Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. Eur J Heart Fail 12:17–24

    Article  PubMed  Google Scholar 

  33. Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C, Vestbo J, Kjoller E, ECHOS Lung Function Study Group (2010) The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 12:685–691

    Article  PubMed  Google Scholar 

  34. Macnee W, Maclay J, McAllister D (2008) Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:824–833

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Wouters EF (2005) Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:26–33

    Article  CAS  PubMed  Google Scholar 

  36. Dimopoulou I, Daganou M, Tsintzas OK, Tzelepis GE (1998) Effects of severity of long-standing congestive heart failure on pulmonary function. Respir Med 92:1321–1325

    Article  CAS  PubMed  Google Scholar 

  37. Sabit R, Bolton CE, Fraser AG, Edwards JM, Edwards PH, Ionescu AA, Cockcroft JR, Shale DJ (2010) Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med 104:1171–1178

    Article  PubMed  Google Scholar 

  38. Voors AA, van der Horst IC (2011) Diabetes: a driver for heart failure. Heart 97:774–780

    Article  PubMed  Google Scholar 

  39. Amato L, Paolisso G, Cacciatore F, Ferrara N, Ferrara P, Canonico S, Varricchio M, Rengo F (1997) Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 23:213–218

    CAS  PubMed  Google Scholar 

  40. Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29–34

    Article  CAS  PubMed  Google Scholar 

  41. Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, Rouleau JL, Sigouin C, Solymoss CB, Tsuyuki R, White M, Yusuf S (2000) Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 21:1368–1375

    Article  CAS  PubMed  Google Scholar 

  42. From AM, Leibson CL, Bursi F, Redfield MM, Weston SA, Jacobsen SJ, Rodeheffer RJ, Roger VL (2006) Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 119:591–599

    Article  PubMed  Google Scholar 

  43. Miki T, Yuda S, Kouzu H, Miura T (2012) Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. doi:10.1007/s10741-012-9313-3

  44. Shah AM, Uno H, Kober L, Velazquez EJ, Maggioni AP, MacDonald MR, Petrie MC, McMurray JJ, Califf RM, Pfeffer MA, Solomon SD (2010) The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. Eur J Heart Fail 12:1229–1237

    Article  CAS  PubMed  Google Scholar 

  45. Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ (2001) Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 38:421–428

    Article  CAS  PubMed  Google Scholar 

  46. Kannel WB, McGee DL (1979) Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 2:120–126

    Article  CAS  PubMed  Google Scholar 

  47. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose) (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:31–40

    Article  Google Scholar 

  48. Berry C, Brett M, Stevenson K, McMurray JJ, Norrie J (2008) Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart 94:296–304

    Article  CAS  PubMed  Google Scholar 

  49. Damman K, Voors AA, Hillege HL, Navis G, Lechat P, van Veldhuisen DJ, Dargie HJ, CIBIS-2 Investigators and Committees (2010) Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 12:974–982

    Article  PubMed  Google Scholar 

  50. Uthoff H, Breidthardt T, Klima T, Aschwanden M, Arenja N, Socrates T, Heinisch C, Noveanu M, Frischknecht B, Baumann U, Jaeger KA, Mueller C (2011) Central venous pressure and impaired renal function in patients with acute heart failure. Eur J Heart Fail 13:432–439

    Article  PubMed  Google Scholar 

  51. Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA (2012) The role of the kidney in heart failure. Eur Heart J 33:2135–2142

    Article  CAS  PubMed  Google Scholar 

  52. Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9:872–878

    Article  PubMed  Google Scholar 

  53. Jois P, Mebazaa A (2012) Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment. Semin Nephrol 32:26–30

    Article  CAS  PubMed  Google Scholar 

  54. Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House A, Katz NM, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P, Acute Dialysis Quality Initiative (ADQI) consensus group (2010) Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 165:54–67

    Article  PubMed  Google Scholar 

  55. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ, Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671–678

    Article  PubMed  Google Scholar 

  56. Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, Cleland JG, van Veldhuisen DJ, Hillege HL (2007) Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 13:599–608

    Article  PubMed  Google Scholar 

  57. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17

    Article  PubMed  Google Scholar 

  58. Jolliffe N (1930) Liver Function in Congestive Heart Failure. J Clin Invest 8:419–433

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, CHARM Investigators (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Eur J Heart Fail 11:170–177

    Article  PubMed  Google Scholar 

  60. Lau GT, Tan HC, Kritharides L (2002) Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 90:1405–1409

    Article  PubMed  Google Scholar 

  61. Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV, HeartMate II, Clinical Investigators (2009) Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 120:2352–2357

    Article  PubMed  Google Scholar 

  62. Kubo SH, Walter BA, John DH, Clark M, Cody RJ (1987) Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med 147:1227–1230

    Article  CAS  PubMed  Google Scholar 

  63. Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D (2000) Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140:111–120

    Article  CAS  PubMed  Google Scholar 

  64. Ambrosy AP, Vaduganathan M, Huffman MD, Khan S, Kwasny MJ, Fought AJ, Maggioni AP, Swedberg K, Konstam MA, Zannad F, Gheorghiade M, EVEREST trial investigators (2012) Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 14:302–311

    Article  CAS  PubMed  Google Scholar 

  65. Bordier P (2009) Sleep apnoea in patients with heart failure. Part I: diagnosis, definitions, prevalence, pathophysiology and haemodynamic consequences. Arch Cardiovasc Dis 102:651–661

    Article  PubMed  Google Scholar 

  66. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235

    Article  CAS  PubMed  Google Scholar 

  67. Muller M, de Jong M, Jaarsma T, Koops A, Voors AA, Nieuwenhuis JA, Wijkstra PJ (2010) Central sleep apnoea syndrome in chronic heart failure: an underestimated and treatable comorbidity. Neth Heart J 18:260–263

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  68. Meguro K, Adachi H, Oshima S, Taniguchi K, Nagai R (2005) Exercise tolerance, exercise hyperpnea and central chemosensitivity to carbon dioxide in sleep apnea syndrome in heart failure patients. Circ J 69:695–699

    Article  PubMed  Google Scholar 

  69. Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93

    Article  PubMed  Google Scholar 

  70. Damy T, Margarit L, Noroc A, Bodez D, Guendouz S, Boyer L, Drouot X, Lamine A, Paulino A, Rappeneau S, Stoica MH, Dubois-Rande JL, Adnot S, Hittinger L, d’Ortho MP (2012) Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail 14(9):1009–1019

    Article  PubMed  Google Scholar 

  71. Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, Schroll S, Montalvan S, Riegger GA, Pfeifer M, Arzt M (2011) Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 13:68–75

    Article  PubMed  Google Scholar 

  72. Kannel WB, Wolf PA, Verter J (1983) Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 250:2942–2946

    CAS  Google Scholar 

  73. Haeusler KG, Laufs U, Endres M (2011) Chronic heart failure and ischemic stroke. Stroke 42:2977–2982

    Article  PubMed  Google Scholar 

  74. Vogels RL, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2007) Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail 9:1003–1009

    Article  PubMed  Google Scholar 

  75. Pullicino PM, Halperin JL, Thompson JL (2000) Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology 54:288–294

    Article  CAS  PubMed  Google Scholar 

  76. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988

    Article  CAS  PubMed  Google Scholar 

  77. Jug B, Vene N, Salobir BG, Sebestjen M, Sabovic M, Keber I (2009) Procoagulant state in heart failure with preserved left ventricular ejection fraction. Int Heart J 50:591–600

    Article  CAS  PubMed  Google Scholar 

  78. Lip GY, Gibbs CR (1999) Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol 33:1424–1426

    Article  CAS  PubMed  Google Scholar 

  79. Divani AA, Vazquez G, Asadollahi M, Qureshi AI, Pullicino P (2009) Nationwide frequency and association of heart failure on stroke outcomes in the United States. J Card Fail 15:11–16

    Article  PubMed  Google Scholar 

  80. Zuccala G, Cattel C, Manes-Gravina E, Di Niro MG, Cocchi A, Bernabei R (1997) Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 63:509–512

    Article  CAS  PubMed  Google Scholar 

  81. Bennett SJ, Sauve MJ (2003) Cognitive deficits in patients with heart failure: a review of the literature. J Cardiovasc Nurs 18:219–242

    Article  PubMed  Google Scholar 

  82. Grimm M, Yeganehfar W, Laufer G, Madl C, Kramer L, Eisenhuber E, Simon P, Kupilik N, Schreiner W, Pacher R, Bunzel B, Wolner E, Grimm G (1996) Cyclosporine may affect improvement of cognitive brain function after successful cardiac transplantation. Circulation 94:1339–1345

    Article  CAS  PubMed  Google Scholar 

  83. Roman DD, Kubo SH, Ormaza S, Francis GS, Bank AJ, Shumway SJ (1997) Memory improvement following cardiac transplantation. J Clin Exp Neuropsychol 19:692–697

    Article  CAS  PubMed  Google Scholar 

  84. Millar K, Asbury AJ, Murray GD (2001) Pre-existing cognitive impairment as a factor influencing outcome after cardiac surgery. Br J Anaesth 86:63–67

    Article  CAS  PubMed  Google Scholar 

  85. Schwarz ER, Rastogi S, Kapur V, Sulemanjee N, Rodriguez JJ (2006) Erectile dysfunction in heart failure patients. J Am Coll Cardiol 48:1111–1119

    Article  PubMed  Google Scholar 

  86. Baraghoush A, Phan A, Willix RD Jr, Schwarz ER (2010) Erectile dysfunction as a complication of heart failure. Curr Heart Fail Rep 7:194–201

    Article  PubMed  Google Scholar 

  87. Saxena PR, Schoemaker RG (1993) Organ blood flow protection in hypertension and congestive heart failure. Am J Med 94:4S–12S

    Article  CAS  PubMed  Google Scholar 

  88. Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW (2003) Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41:1797–1804

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

VvD, KD, PvdM, PJW, GJL, AvB, DJvV and AAV have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adriaan A. Voors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Deursen, V.M., Damman, K., van der Meer, P. et al. Co-morbidities in heart failure. Heart Fail Rev 19, 163–172 (2014). https://doi.org/10.1007/s10741-012-9370-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-012-9370-7

Keywords

Navigation